Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Malignant Melanoma

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 124 articles: HTML format Text format

Single Articles

January 2012
1. ERDAG G , Schaefer JT, Smolkin ME, Deacon DH, et al
   Immunotype and Immunohistologic Characteristics of Tumor Infiltrating Immune Cells are Associated with Clinical Outcome in Metastatic Melanoma.
   Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. PIETRA G , Manzini C, Rivara S, Vitale M, et al
   Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.
   Cancer Res. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
3. JARRETT SG , Novak M, Dabernat S, Daniel JY, et al
   Metastasis suppressor NM23-H1 promotes repair of UV-induced DNA damage and suppresses UV-induced melanomagenesis.
   Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. GRANGE M , Buferne M, Verdeil G, Leserman L, et al
   Activated STAT5 promotes long-lived cytotoxic CD8+ T cells that induce regression of autochthonous melanoma.
   Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. YI H , Guo C, Yu X, Gao P, et al
   Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity.
   Cancer Res. 2011;71:6611-20.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
6. NAN H , Du M, De Vivo I, Manson JE, et al
   Shorter Telomeres Associate with a Reduced Risk of Melanoma Development.
   Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. ZIGLER M , Kamiya T, Brantley EC, Villares GJ, et al
   PAR-1 and Thrombin: The Ties That Bind the Microenvironment to Melanoma Metastasis.
   Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. NIERKENS S , den Brok MH, Garcia Z, Togher S, et al
   Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells.
   Cancer Res. 2011;71:6428-37.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. KREITER S , Diken M, Selmi A, Diekmann J, et al
   FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccines.
   Cancer Res. 2011;71:6132-42.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
10. HONG M , Puaux AL, Huang C, Loumagne L, et al
    Chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T cell infiltration and tumor control.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. NOMAN MZ , Janji B, Kaminska B, Van Moer K, et al
    Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression.
    Cancer Res. 2011;71:5976-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. JAVELAUD D , Alexaki VI, Dennler S, Mohammad KS, et al
    TGF-beta/SMAD/GLI2 signaling axis in cancer progression and metastasis.
    Cancer Res. 2011;71:5606-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. DONDOSSOLA E , Gasparri AM, Colombo B, Sacchi A, et al
    Chromogranin A restricts drug penetration and limits the ability of NGR-TNF to enhance chemotherapeutic efficacy.
    Cancer Res. 2011;71:5881-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. HANGALAPURA BN , Oosterhoff D, de Groot J, Boon L, et al
    Potent antitumor immunity generated by a CD40-targeted adenoviral vaccine.
    Cancer Res. 2011;71:5827-37.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
15. TERME M , Ullrich E, Aymeric L, Meinhardt K, et al
    IL-18 induces PD-1-dependent immunosuppression in cancer.
    Cancer Res. 2011;71:5393-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. FU T , He Q, Sharma P
    The ICOS/ICOSL pathway is required for optimal antitumor responses mediated by anti-CTLA-4 therapy.
    Cancer Res. 2011;71:5445-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. SHI H , Kong X, Ribas A, Lo RS, et al
    Combinatorial Treatments That Overcome PDGFR{beta}-Driven Resistance of Melanoma Cells to V600EB-RAF Inhibition.
    Cancer Res. 2011;71:5067-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. PALASKAS N , Larson SM, Schultz N, Komisopoulou E, et al
    18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers.
    Cancer Res. 2011;71:5164-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
19. ZHANG K , Kim S, Cremasco V, Hirbe AC, et al
    CD8+ T cells regulate bone tumor burden independent of osteoclast resorption.
    Cancer Res. 2011;71:4799-808.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. YANG L , Chen G, Mohanty S, Scott G, et al
    GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. MURUGAN AK , Xing M
    Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene.
    Cancer Res. 2011;71:4403-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. LEE AS , Kim DH, Lee JE, Jung YJ, et al
    Erythropoietin induces lymph node lymphangiogenesis and lymph node tumor metastasis.
    Cancer Res. 2011;71:4506-17.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
23. YAMAUCHI Y , Furukawa K, Hamamura K, Furukawa K, et al
    Positive feedback loop between PI3K-Akt-mTORC1 signaling and the lipogenic pathway boosts Akt signaling: Induction of the lipogenic pathway by a melanoma antigen.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. SEN A , Capitano ML, Spernyak JA, Schueckler JT, et al
    Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor models.
    Cancer Res. 2011;71:3872-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. LEE H , Deng J, Xin H, Liu Y, et al
    A requirement of STAT3 DNA binding precludes Th-1 immunostimulatory gene expression by NF-kappaB in tumors.
    Cancer Res. 2011;71:3772-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
26. DEFRESNE F , Bouzin C, Grandjean M, Dieu M, et al
    Preconditioned endothelial progenitor cells reduce formation of melanoma metastases through SPARC-driven cell-cell interactions and endocytosis.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. LIU L , Nam S, Tian Y, Yang F, et al
    6-Bromoindirubin-3'-Oxime Inhibits JAK/STAT3 Signaling and Induces Apoptosis of Human Melanoma Cells.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. LANGER HF , Orlova VV, Xie C, Kaul S, et al
    A novel function of Junctional Adhesion Molecule-C in mediating melanoma cell metastasis.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. KHAITAN D , Dinger ME, Mazar J, Crawford J, et al
    The Melanoma-Upregulated Long Noncoding RNA SPRY4-IT1 Modulates Apoptosis and Invasion.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. AMELN AK , Muschter A, Mamlouk S, Kalucka J, et al
    Inhibition of HIF prolyl hydroxylase-2 blocks tumor growth in mice through the antiproliferative activity of TGFbeta.
    Cancer Res. 2011;71:3306-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. ARANDA F , Llopiz D, Diaz-Valdes N, Riezu-Boj JI, et al
    Adjuvant combination and antigen targeting as a strategy to induce polyfunctional and high-avidity T-cell responses against poorly immunogenic tumors.
    Cancer Res. 2011;71:3214-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
32. MANUEL ER , Blache CA, Paquette R, Kaltcheva TI, et al
    Enhancement of Cancer Vaccine Therapy by Systemic Delivery of a Tumor Targeting Salmonella-based STAT3 shRNA Suppresses the Growth of Established Melanoma Tumors.
    Cancer Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
33. CHEN J , Shen Q, Labow M, Gaither LA, et al
    Protein kinase D3 sensitizes RAF inhibitor RAF265 in melanoma cells by preventing reactivation of MAPK signaling.
    Cancer Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
34. STAGG J , Divisekera U, Duret H, Sparwasser T, et al
    CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis.
    Cancer Res. 2011;71:2892-900.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. ROOS WP , Jost E, Belohlavek C, Nagel G, et al
    Intrinsic anticancer drug resistance of malignant melanoma cells is abrogated by interferon-ss and valproic acid.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. HOOD JL , San Roman S, Wickline SA
    Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. ZIGLER M , Villares GJ, Dobroff AS, Wang H, et al
    Expression of Id-1 is regulated by MCAM/MUC18: A missing link in melanoma progression.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. BOUDREAU JE , Stephenson KB, Wang F, Ashkar AA, et al
    IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells.
    Cancer Res. 2011;71:2497-506.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. BURNETTE BC , Liang H, Lee Y, Chlewicki L, et al
    The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity.
    Cancer Res. 2011;71:2488-96.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
40. SORENSEN RB , Kollgaard T, Andersen RS, van den Berg JH, et al
    Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2.
    Cancer Res. 2011;71:2038-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. CIVENNI G , Walter A, Kobert N, Mihic-Probst D, et al
    Human CD271-Positive Melanoma Stem Cells Associated with Metastasis Establish Tumor Heterogeneity and Long-Term Growth.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
42. ROSE AE , Poliseno L, Wang J, Clark M, et al
    Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. STINE MJ , Wang CJ, Moriarty WF, Ryu B, et al
    Integration of Genotypic and Phenotypic Screening Reveals Molecular Mediators of Melanoma-Stromal Interaction.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. PARAISO KH , Xiang Y, Rebecca VW, Abel EV, et al
    PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. SCHIAVONI G , Sistigu A, Valentini M, Mattei F, et al
    Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis.
    Cancer Res. 2011;71:768-78.
    PubMed     Text format     Related articles   
    
    
    
    
46. NAKAZAWA Y , Arai H, Fujita N
    The novel metastasis promoter Merm1/Wbscr22 enhances tumor cell survival in the vasculature by suppressing Zac1/p53-dependent apoptosis.
    Cancer Res. 2011;71:1146-55.
    PubMed     Text format     Related articles   
    
    
    
    
47. VIAUD S , Flament C, Zoubir M, Pautier P, et al
    Cyclophosphamide induces differentiation of Th17 cells in cancer patients.
    Cancer Res. 2011;71:661-5.
    PubMed     Text format     Related articles   
    
    
    
    
48. SIM H , Bibee K, Wickline S, Sept D, et al
    Pharmacokinetic modeling of tumor bioluminescence implicates efflux, and not influx, as the bigger hurdle in cancer drug therapy.
    Cancer Res. 2011;71:686-92.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
49. HAN J , Qureshi A, Nan H, Zhang J, et al
    A Germline Variant in the Interferon Regulatory Factor 4 Gene as a Novel Skin Cancer Risk Locus.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. REROLE AL , Gobbo J, De Thonel A, Schmitt E, et al
    Peptides and aptamers targeting HSP70: a novel approach for anticancer chemotherapy.
    Cancer Res. 2011;71:484-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. FRANK NY , Schatton T, Kim S, Zhan Q, et al
    VEGFR-1 expressed by malignant melanoma initiating cells is required for tumor growth.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. CORBIERE V , Chapiro J, Stroobant V, Ma W, et al
    Antigen spreading contributes to MAGE vaccination-induced regression of melanoma metastases.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. LI CM , Wang Z, Lu Y, Ahn S, et al
    Biological activity of 4-substituted methoxybenzoyl-aryl-thiazole: an active microtubule inhibitor.
    Cancer Res. 2011;71:216-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
54. JAZIREHI AR , Baritaki S, Koya RC, Bonavida B, et al
    Molecular Mechanism of MART-1+/A*0201+ Human Melanoma Resistance to Specific CTL-Killing Despite Functional Tumor-CTL Interaction.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. DIAZ-VALDES N , Basagoiti M, Dotor J, Aranda F, et al
    Induction of Monocyte chemoattractant protein-1 and Interleukin-10 by Transforming growth factor{beta}1 in melanoma enhances tumor infiltration and immunosuppression.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. HARDY KM , Kirschmann DA, Seftor EA, Margaryan NV, et al
    Regulation of the embryonic morphogen nodal by notch4 facilitates manifestation of the aggressive melanoma phenotype.
    Cancer Res. 2010;70:10340-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. VAN DEVENTER HW , Burgents JE, Wu QP, Woodford RM, et al
    The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells.
    Cancer Res. 2010;70:10161-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. SCHOENFELD J , Jinushi M, Nakazaki Y, Wiener D, et al
    Active immunotherapy induces antibody responses that target tumor angiogenesis.
    Cancer Res. 2010;70:10150-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. LAURENT C , Valet F, Planque N, Silveri L, et al
    HIGH PTP4A3 PHOSPHATASE EXPRESSION CORRELATES WITH METASTATIC RISK IN UVEAL MELANOMA PATIENTS.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. KUJAWSKI M , Zhang C, Herrmann A, Reckamp K, et al
    Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects.
    Cancer Res. 2010;70:9599-610.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
61. MARTIN-OROZCO N , Li Y, Wang Y, Liu S, et al
    Melanoma Cells Express ICOS Ligand to Promote the Activation and Expansion of T-Regulatory Cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. MOHAMMAD KS , Javelaud D, Fournier PG, Niewolna M, et al
    The Transforming Growth Factor-{beta} Receptor I Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. ESCOBAR B , de Carcer G, Fernandez-Miranda G, Cascon A, et al
    Brick1 is an essential regulator of actin cytoskeleton required for embryonic development and cell transformation.
    Cancer Res. 2010;70:9349-59.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. LI J , Li G
    Cell Cycle Regulator ING4 Is a Suppressor of Melanoma Angiogenesis that Is Regulated by the Metastasis Suppressor BRMS1.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. KIM M , Koh YJ, Kim KE, Koh BI, et al
    CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. MUMPRECHT V , Honer M, Vigl B, Proulx ST, et al
    In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography.
    Cancer Res. 2010;70:8842-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. DE KEIZER PL , Packer LM, Szypowska AA, Riedl-Polderman PE, et al
    Activation of forkhead box O transcription factors by oncogenic BRAF promotes p21cip1-dependent senescence.
    Cancer Res. 2010;70:8526-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. FERRAND N , Atfi A, Prunier C
    The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-{beta} type I receptor.
    Cancer Res. 2010;70:8457-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. LY LV , Sluijter M, Versluis M, Luyten GP, et al
    Peptide vaccination after T-cell transfer causes massive clonal expansion, tumor eradication, and manageable cytokine storm.
    Cancer Res. 2010;70:8339-46.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
70. GOPAL YN , Deng W, Woodman SE, Komurov K, et al
    Basal and Treatment-Induced Activation of AKT Mediates Resistance to Cell Death by AZD6244 (ARRY-142886) in Braf-Mutant Human Cutaneous Melanoma Cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. GARCIA-BARROS M , Thin TH, Maj J, Cordon-Cardo C, et al
    Impact of stromal sensitivity on radiation response of tumors implanted in SCID hosts revisited.
    Cancer Res. 2010;70:8179-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. WHITTAKER S , Menard D, Kirk R, Ogilvie L, et al
    A novel, selective, and efficacious nanomolar pyridopyrazinone inhibitor of V600EBRAF.
    Cancer Res. 2010;70:8036-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. LANATI S , Dunn DB, Roussigne M, Emmett MS, et al
    Chemotrap-1: an engineered soluble receptor that blocks chemokine-induced migration of metastatic cancer cells in vivo.
    Cancer Res. 2010;70:8138-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. KLAGES K , Mayer CT, Lahl K, Loddenkemper C, et al
    Selective Depletion of Foxp3+ Regulatory T Cells Improves Effective Therapeutic Vaccination against Established Melanoma.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. HERRMANN A , Kortylewski M, Kujawski M, Zhang C, et al
    Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells.
    Cancer Res. 2010;70:7455-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. GENG D , Zheng L, Srivastava R, Velasco-Gonzalez C, et al
    Amplifying TLR-MyD88 signals within tumor-specific T cells enhances antitumor activity to suboptimal levels of weakly immunogenic tumor antigens.
    Cancer Res. 2010;70:7442-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. DEMOTTE N , Wieers G, Van Der Smissen P, Moser M, et al
    A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice.
    Cancer Res. 2010;70:7476-88.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
78. ANICHINI A , Molla A, Vegetti C, Bersani I, et al
    Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. PROULX ST , Luciani P, Derzsi S, Rinderknecht M, et al
    Quantitative imaging of lymphatic function with liposomal indocyanine green.
    Cancer Res. 2010;70:7053-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. PALERMO B , Del Bello D, Sottini A, Serana F, et al
    Dacarbazine Treatment before Peptide Vaccination Enlarges T-Cell Repertoire Diversity of Melan-A-Specific, Tumor-Reactive CTL in Melanoma Patients.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. KERKAR SP , Muranski P, Kaiser A, Boni A, et al
    Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts.
    Cancer Res. 2010;70:6725-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
82. BOWDEN NA , Ashton KA, Avery-Kiejda KA, Zhang XD, et al
    Nucleotide excision repair gene expression after cisplatin treatment in melanoma.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. MCKENZIE JA , Liu T, Goodson A, Grossman D, et al
    Survivin enhances motility of melanoma cells by supporting Akt activation and {alpha}5 integrin upregulation.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. TRIMMER C , Whitaker-Menezes D, Bonuccelli G, Milliman JN, et al
    CAV1 inhibits metastatic potential in melanomas through suppression of the Integrin/Src/FAK signaling pathway.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. SINNBERG T , Menzel M, Kaesler S, Biedermann T, et al
    Suppression of Casein Kinase 1{alpha} in Melanoma Cells Induces a Switch in {beta}-Catenin Signaling to Promote Metastasis.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. THIJSSEN VL , Barkan B, Shoji H, Aries IM, et al
    Tumor cells secrete galectin-1 to enhance endothelial cell activity.
    Cancer Res. 2010;70:6216-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. SHRIMALI RK , Yu Z, Theoret MR, Chinnasamy D, et al
    Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer.
    Cancer Res. 2010;70:6171-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
88. SHAO Y , Aplin AE
    Akt3-Mediated Resistance to Apoptosis in B-RAF-Targeted Melanoma Cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. HUH SJ , Liang S, Sharma A, Dong C, et al
    Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development.
    Cancer Res. 2010;70:6071-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. CHEN DY , Liu H, Takeda S, Tu HC, et al
    Taspase1 functions as a non-oncogene addiction protease that coordinates cancer cell proliferation and apoptosis.
    Cancer Res. 2010;70:5358-67.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
91. TOMIHARI M , Chung JS, Akiyoshi H, Cruz PD Jr, et al
    DC-HIL/Glycoprotein Nmb Promotes Growth of Melanoma in Mice by Inhibiting the Activation of Tumor-Reactive T Cells.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. YANG H , Higgins B, Kolinsky K, Packman K, et al
    RG7204 (PLX4032), a Selective BRAFV600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma Models.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. BALJINNYAM E , De Lorenzo MS, Xie LH, Iwatsubo M, et al
    Exchange Protein Directly Activated by Cyclic AMP Increases Melanoma Cell Migration by a Ca2+-Dependent Mechanism.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. BONI A , Cogdill AP, Dang P, Udayakumar D, et al
    Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. NISANCIOGLU MH , Betsholtz C, Genove G
    The absence of pericytes does not increase the sensitivity of tumor vasculature to vascular endothelial growth factor-A blockade.
    Cancer Res. 2010;70:5109-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. WANG YC , He F, Feng F, Liu XW, et al
    Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses.
    Cancer Res. 2010;70:4840-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. MILAGRE C , Dhomen N, Geyer FC, Hayward R, et al
    A Mouse Model of Melanoma Driven by Oncogenic KRAS.
    Cancer Res. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. MALIK G , Knowles LM, Dhir R, Xu S, et al
    Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion.
    Cancer Res. 2010;70:4327-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. YANG JY , Chang CJ, Xia W, Wang Y, et al
    Activation of FOXO3a is sufficient to reverse mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor chemoresistance in human cancer.
    Cancer Res. 2010;70:4709-18.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. CASAL C , Torres-Collado AX, Plaza-Calonge Mdel C, Martino-Echarri E, et al
     ADAMTS1 contributes to the acquisition of an endothelial-like phenotype in plastic tumor cells.
     Cancer Res. 2010;70:4676-86.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. WONGTHIDA P , Diaz RM, Galivo F, Kottke T, et al
     Type III IFN interleukin-28 mediates the antitumor efficacy of oncolytic virus VSV in immune-competent mouse models of cancer.
     Cancer Res. 2010;70:4539-49.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. CHEN S , Blank JL, Peters T, Liu XJ, et al
     Genome-wide siRNA screen for modulators of cell death induced by proteasome inhibitor bortezomib.
     Cancer Res. 2010;70:4318-26.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2010
103. GADDAMEEDHI S , Kemp MG, Reardon JT, Shields JM, et al
     Similar Nucleotide Excision Repair Capacity in Melanocytes and Melanoma Cells.
     Cancer Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. FREEMAN SA , McLeod SJ, Dukowski J, Austin P, et al
     Preventing the Activation or Cycling of the Rap1 GTPase Alters Adhesion and Cytoskeletal Dynamics and Blocks Metastatic Melanoma Cell Extravasation into the Lungs.
     Cancer Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. POSCHKE I , Mougiakakos D, Hansson J, Masucci GV, et al
     Immature Immunosuppressive CD14+HLA-DR-/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign.
     Cancer Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. LI L , Shukla S, Lee A, Garfield SH, et al
     The Skin Cancer Chemotherapeutic Agent Ingenol-3-Angelate (PEP005) Is a Substrate for the Epidermal Multidrug Transporter (ABCB1) and Targets Tumor Vasculature.
     Cancer Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. PHILIPPIDOU D , Schmitt M, Moser D, Margue C, et al
     Signatures of MicroRNAs and Selected MicroRNA Target Genes in Human Melanoma.
     Cancer Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. JOYAL JL , Barrett JA, Marquis JC, Chen J, et al
     Preclinical Evaluation of an 131I-Labeled Benzamide for Targeted Radiotherapy of Metastatic Melanoma.
     Cancer Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     April 2010
109. BHUTIA SK , Dash R, Das SK, Azab B, et al
     Mechanism of Autophagy to Apoptosis Switch Triggered in Prostate Cancer Cells by Antitumor Cytokine Melanoma Differentiation-Associated Gene 7/Interleukin-24.
     Cancer Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. SOUDJA SM , Wehbe M, Mas A, Chasson L, et al
     Tumor-Initiated Inflammation Overrides Protective Adaptive Immunity in an Induced Melanoma Model in Mice.
     Cancer Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. BURNS WR , Zhao Y, Frankel TL, Hinrichs CS, et al
     A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomas.
     Cancer Res. 2010;70:3027-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. GARMY-SUSINI B , Avraamides CJ, Schmid MC, Foubert P, et al
     Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis.
     Cancer Res. 2010;70:3042-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. DE HAIJ S , Jansen JH, Boross P, Beurskens FJ, et al
     In vivo cytotoxicity of type I CD20 antibodies critically depends on Fc receptor ITAM signaling.
     Cancer Res. 2010;70:3209-17.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. GIULIANO S , Cheli Y, Ohanna M, Bonet C, et al
     Microphthalmia-Associated Transcription Factor Controls the DNA Damage Response and a Lineage-Specific Senescence Program in Melanomas.
     Cancer Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2010
115. ABEL EV , Aplin AE
     FOXD3 Is a Mutant B-RAF-Regulated Inhibitor of G1-S Progression in Melanoma Cells.
     Cancer Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. MULLER AJ , DuHadaway JB, Jaller D, Curtis P, et al
     Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate.
     Cancer Res. 2010;70:1845-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2010
117. SEEGER JM , Schmidt P, Brinkmann K, Hombach AA, et al
     The Proteasome Inhibitor Bortezomib Sensitizes Melanoma Cells toward Adoptive CTL Attack.
     Cancer Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. JANE-VALBUENA J , Widlund HR, Perner S, Johnson LA, et al
     An Oncogenic Role for ETV1 in Melanoma.
     Cancer Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. LEE C , Safdie FM, Raffaghello L, Wei M, et al
     Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index.
     Cancer Res. 2010;70:1564-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2010
120. CONFORTI R , Ma Y, Morel Y, Paturel C, et al
     Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands.
     Cancer Res. 2010;70:490-500.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. DU W , Takuwa N, Yoshioka K, Okamoto Y, et al
     S1P(2), the G protein-coupled receptor for sphingosine-1-phosphate, negatively regulates tumor angiogenesis and tumor growth in vivo in mice.
     Cancer Res. 2010;70:772-81.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. SCHATTON T , Schutte U, Frank NY, Zhan Q, et al
     Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells.
     Cancer Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. WANG W , Niendorf KB, Patel D, Blackford A, et al
     Estimating CDKN2A Carrier Probability and Personalizing Cancer Risk Assessments in Hereditary Melanoma Using MelaPRO.
     Cancer Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
124. CUI Y , Borysova MK, Johnson JO, Guadagno TM, et al
     Oncogenic B-RafV600E Induces Spindle Abnormalities, Supernumerary Centrosomes, and Aneuploidy in Human Melanocytic Cells.
     Cancer Res. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: